Dr Lalchand. Lab

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE871Z01013
  • NSEID:
  • BSEID: 541299
INR
9.62
-0.5 (-4.94%)
BSENSE

Apr 17

BSE+NSE Vol: 68000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002986,
    "name": "Dr Lalchand. Lab",
    "stock_name": "Dr Lalchand. Lab",
    "full_name": "Dr Lalchandani Labs Ltd",
    "name_url": "stocks-analysis/dr-lalchand-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.62",
    "chg": -0.5,
    "chgp": "-4.94%",
    "dir": -1,
    "prev_price": "10.12",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541299,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE871Z01013",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": 68000,
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lalchand-lab-1002986-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 53,
    "sid": "1002986",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lalchandani-labs-1002986"
  },
  "announcements": [
    {
      "caption": "Reply To The Clarification Sought By BSE",
      "datetime": "13-Apr-2026",
      "details": "Reply to the clarification sought by exchange dated April 13 2026",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Dr Lalchandani Labs Ltd",
      "datetime": "13-Apr-2026",
      "details": "The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI DP Regulations for Quarter ended March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lalchandani Labs Ltd has announced <strong>1:1</strong> rights issue, ex-date: 27 Jan 26",
          "dt": "2026-01-27",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Reply To The Clarification Sought By BSE

13-Apr-2026 | Source : BSE

Reply to the clarification sought by exchange dated April 13 2026

Clarification sought from Dr Lalchandani Labs Ltd

13-Apr-2026 | Source : BSE

The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Apr-2026 | Source : BSE

Certificate under Regulation 74(5) of SEBI DP Regulations for Quarter ended March 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Dr Lalchandani Labs Ltd has announced 1:1 rights issue, ex-date: 27 Jan 26